tadalafil has been researched along with Sex Disorders in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 11 (68.75) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Baniotopoulos, P; Dimitroulas, T; Hatzichristodoulou, G; Minopoulou, I; Pyrgidis, N; Sokolakis, I; Tishukov, M | 2 |
| Borghi, C; Dell'Atti, L | 1 |
| Hashimoto, Y; Hatakeyama, S; Matsumoto, T; Narita, T; Ohyama, C; Yoneyama, T | 1 |
| De Nucci, G; Mónica, FZ | 1 |
| Gao, YJ; Jin, BF; Sun, DL; Xia, GS; Xia, XY; Xu, FS; Zhang, HJ; Zhang, XD | 1 |
| Bullemor-Day, P; Chukwujekwu, C; Hawton, K; Lubin, J; Rudkin, L; Taylor, MJ | 1 |
| Hashimoto, M; Hayashi, T; Kikuti, T; Minami, T; Nagai, Y; Nishimoto, M; Nozawa, M; Saitou, Y; Shimizu, N; Toyoda, S; Tsuji, H; Uemura, H; Yamamoto, Y; Yoshimura, K | 1 |
| Fukagai, T; Hayashi, K; Igarashi, A; Koshikiya, A; Morita, M; Sasaki, H | 1 |
| Chivers, ML; Rosen, RC | 1 |
| Demirtas, A; Ekmekcioglu, O; Gökçe, A; Halis, F | 1 |
| Amato, B; Iacono, F; Illiano, E; Prezioso, D; Romeo, G; Ruffo, A | 1 |
| Cannizzaro, C; Cannizzaro, E; Lo Coco, D; Lopez, G | 1 |
| Sohn, W | 1 |
| Minhas, S; Ralph, DJ; Wang, WF | 1 |
| Marmo Lucon, A; Mattos, RM; Srougi, M | 1 |
8 review(s) available for tadalafil and Sex Disorders
| Article | Year |
|---|---|
Treatment of Sexual Dysfunction in Women with Systemic Autoimmune Rheumatic Disorders: A Systematic Review.
Topics: Androgens; Cyclic Nucleotide Phosphodiesterases, Type 5; Female; Humans; Lubricants; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sexual Dysfunction, Physiological; Tadalafil; Testosterone | 2022 |
Treatment of Sexual Dysfunction in Women with Systemic Autoimmune Rheumatic Disorders: A Systematic Review.
Topics: Androgens; Female; Humans; Lupus Erythematosus, Systemic; Scleroderma, Systemic; Sexual Dysfunction, Physiological; Tadalafil | 2022 |
Tadalafil once daily: Narrative review of a treatment option for female sexual dysfunctions (FSD) in midlife and older women.
Topics: Aged; Female; Humans; Menopause; Middle Aged; Orgasm; Prevalence; Risk Factors; Sexual Dysfunction, Physiological; Tadalafil; Vasodilator Agents | 2017 |
Tadalafil for the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Animals; Erectile Dysfunction; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Tadalafil; Treatment Outcome | 2019 |
Strategies for managing sexual dysfunction induced by antidepressant medication.
Topics: Antidepressive Agents; Bupropion; Carbolines; Drug Substitution; Female; Humans; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Randomized Controlled Trials as Topic; Sex Factors; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Tadalafil | 2013 |
Phosphodiesterase type 5 inhibitors and female sexual response: faulty protocols or paradigms?
Topics: Animals; Carbolines; Clitoris; Female; Humans; Imidazoles; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Piperazines; Purines; Sex Factors; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vagina; Vardenafil Dihydrochloride; Women's Health | 2010 |
[Pleasure and pain in sexual relations. The basis and reasons for sex counseling by the general practitioner].
Topics: Adult; Carbolines; Erectile Dysfunction; Family Practice; Female; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Physician-Patient Relations; Piperazines; Purines; Risk Factors; Sex Counseling; Sex Factors; Sexual Dysfunction, Physiological; Sexuality; Sildenafil Citrate; Sulfones; Tadalafil; Vasodilator Agents | 2003 |
Phosphodiesterase 5 inhibitors in the treatment of premature ejaculation.
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Carbolines; Cyclic Nucleotide Phosphodiesterases, Type 5; Ejaculation; Humans; Imidazoles; Male; Phosphodiesterase Inhibitors; Piperazines; Purines; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride | 2006 |
5 trial(s) available for tadalafil and Sex Disorders
| Article | Year |
|---|---|
Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.
Topics: 5-alpha Reductase Inhibitors; Aged; Dose-Response Relationship, Drug; Drug Substitution; Dutasteride; Humans; Lower Urinary Tract Symptoms; Male; Patient Satisfaction; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Severity of Illness Index; Sexual Dysfunction, Physiological; Tadalafil; Treatment Outcome | 2019 |
[Yangjing capsule plus low-dose tadalafil for functional anejaculation].
Topics: Adult; Capsules; Carbolines; Drug Therapy, Combination; Drugs, Chinese Herbal; Humans; Infertility, Male; Male; Phytotherapy; Sexual Dysfunction, Physiological; Tadalafil; Treatment Outcome; Young Adult | 2012 |
The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: a double-blind laboratory setting study.
Topics: Administration, Oral; Adult; Carbolines; Dose-Response Relationship, Drug; Ejaculation; Follow-Up Studies; Humans; Imidazoles; Male; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Sexual Dysfunction, Physiological; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Outcome; Triazines; Vardenafil Dihydrochloride; Young Adult | 2011 |
Sexual asthenia: Tradamixina versus Tadalafil 5 mg daily.
Topics: Acetylglucosamine; Aged; Aged, 80 and over; Androgens; Biomarkers; Carbolines; Double-Blind Method; Drug Administration Schedule; Drug Combinations; Erectile Dysfunction; Glucosamine; Humans; Libido; Male; Phaeophyceae; Phosphodiesterase 5 Inhibitors; Phytotherapy; Plant Extracts; Plant Preparations; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Tadalafil; Testosterone; Treatment Outcome; Tribulus | 2012 |
Tadalafil and fluoxetine in premature ejaculation: prospective, randomized, double-blind, placebo-controlled study.
Topics: Adult; Carbolines; Double-Blind Method; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sexual Dysfunction, Physiological; Tadalafil; Time Factors | 2008 |
3 other study(ies) available for tadalafil and Sex Disorders
| Article | Year |
|---|---|
[The Effect of Tadalafil on Sexual Function, Urinary Function and Health-Related Quality of Life in Patients Treated with Brachytherapy].
Topics: Brachytherapy; Humans; Male; Middle Aged; Prostatic Neoplasms; Quality of Life; Sexual Dysfunction, Physiological; Tadalafil; Urination | 2015 |
[A Study of the Efficacy of the Additional Administration of Tadalafil in Japanese Men with α1-Blocker-Resistant LUTS/BPH].
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Asian People; Drug Resistance; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Phosphodiesterase 5 Inhibitors; Prostatic Hyperplasia; Quality of Life; Sexual Dysfunction, Physiological; Tadalafil; Treatment Outcome; Urodynamics | 2016 |
Stroke after tadalafil use.
Topics: Brain; Carbolines; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Phosphodiesterase 5 Inhibitors; Sexual Dysfunction, Physiological; Stroke; Tadalafil | 2013 |